Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew.
J Michael Bostwick, Chaitanya Pabbati, Jennifer R Geske...
https://pubmed.ncbi.nlm.nih.gov/27523496Actively Recruiting
Led by University of Bern · Updated on 2026-01-22
156
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers aim to understand the psychological and neuropsychological patterns that influence suicidal thoughts and behaviors, focusing on people who have attempted suicide. The study evaluates how a brief therapy called the Attempted Suicide Short Intervention Program (ASSIP) affects these patterns compared to standard care plus a resource interview (STAR). This is part of a larger research effort involving three projects, with this project (Project 2) focusing on the therapy's impact over time. Participants who have previously attempted suicide and agreed to join Project 2 are randomly assigned to receive either the ASSIP intervention or the STAR standard care. ASSIP involves three to four therapy sessions of about 50 minutes each, where patients share their personal story and work with therapists to develop safety strategies. The STAR group receives three face-to-face sessions focusing on risk assessment and activating personal resources. Both therapies take place at the University Hospital of Psychiatry and Psychotherapy Bern in Switzerland. Participants are assessed at three time points: within one week after consent, after completing the therapy sessions (around four weeks later), and 12 months after the initial assessment. The assessments measure inhibitory control, attention, self-efficacy, locus of control, psychological pain, suicidal ideation and behavior, and movement synchrony during therapy sessions. The study monitors changes in these factors over time to understand the therapy effects and psychological processes involved.
CONDITIONS
Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 2
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 4 weeks
Participants receive either the ASSIP brief therapy consisting of 3 to 4 sessions of approximately 50 minutes each, or the STAR standard care plus resource interview with three face-to-face sessions focusing on suicide risk assessment and resource activation.
3 to 4 sessions (in-person)
Duration - 12 months
Participants are assessed on several neuropsychological and psychological process factors at 4 weeks and 12 months after the baseline assessment to evaluate the effects of the intervention.
2 visits (in-person) at 4 weeks and 12 months after baseline
Total: 1 location
1
University Hospital of Psychiatry and Psychotherapy, University of Bern
Bern, Switzerland, 3008
Actively Recruiting
A
Anja C. Gysin-Maillart, PhD
K
Kristina Adorjan, Prof. Dr. med.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
J Michael Bostwick, Chaitanya Pabbati, Jennifer R Geske...
https://pubmed.ncbi.nlm.nih.gov/27523496Mette Ystgaard, Ella Arensman, Keith Hawton...
https://pubmed.ncbi.nlm.nih.gov/19028399E David Klonsky, Alexis May
https://pubmed.ncbi.nlm.nih.gov/21198330Dana Lizardi, Barbara Stanley
https://pubmed.ncbi.nlm.nih.gov/21123401Janette L Smith, Richard P Mattick, Sharna D Jamadar...
https://pubmed.ncbi.nlm.nih.gov/25195081M K Nock, I Hwang, N A Sampson...
https://pubmed.ncbi.nlm.nih.gov/19337207Dajana Rath, Nina Hallensleben, Heide Glaesmer...
https://pubmed.ncbi.nlm.nih.gov/28718868Fabian Ramseyer, Wolfgang Tschacher
https://pubmed.ncbi.nlm.nih.gov/21639608CM MacLeod, PA MacDonald
https://pubmed.ncbi.nlm.nih.gov/11025281D V Sheehan, Y Lecrubier, K H Sheehan...
https://pubmed.ncbi.nlm.nih.gov/9881538